Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 625 E. KALISTE SALOOM RD. LAFAYETTE LA 70508 |
Tel: | 1-905-3261888 |
Website: | https://www.viemed.com |
IR: | See website |
Key People | ||
Michael Moore President | Casey Hoyt Chief Executive Officer, Director | Trae Paul Fitzgerald Chief Financial Officer |
W. Todd Zehnder Chief Operating Officer, Director | Jerome Richard II Cambre Vice President - Sales | Patrick Eagan General Counsel, Company Secretary | William Frazier Chief Medical Officer, Director |
Business Overview |
Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company's service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company's products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed). |
Financial Overview |
For the three months ended 31 March 2024, Viemed Healthcare Inc revenues increased 28% to $50.6M. Net income increased 6% to $1.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Selling, General & Administrative Expens increase of 26% to $24.8M (expense), loss on disposal of ppe increase from $22K (income) to $213K (expense). |
Employees: | 996 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $276.86M as of Mar 31, 2024 |
Annual revenue (TTM): | $194.05M as of Mar 31, 2024 |
EBITDA (TTM): | $38.89M as of Mar 31, 2024 |
Net annual income (TTM): | $10.33M as of Mar 31, 2024 |
Free cash flow (TTM): | $8.47M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 38,820,766 as of Apr 26, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |